ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an ...
Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, pharmaceutical, diagnostics and bioprocessing markets worldwide. In 2013, Bio-Techne ...
Bio-Techne Corporation is a market leader in life science reagents, well-positioned for long-term growth in cell and gene therapeutics and organoid solutions. Despite strong fundamentals and recurring ...
Miami is no stranger to fitness trends, but this latest one is turning up the heat in a whole new<a class="excerpt-read-more" ...
The Graduate Architecture, Urban Design, and Landscape Architecture programs (GA/LA/UD) at Pratt Institute are proud to participate in the Biodesign Challenge (BDC) with their project submission ...
Fintel reports that on November 20, 2025, Argus Research maintained coverage of Bio-Techne (NasdaqGS:TECH) with a Buy recommendation. As of November 17, 2025, the average one-year price target for Bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback